Evidence map›Paper›PMID 35982233›Full record

ArticleNature chemistry2022

Biosynthesis and characterization of fuscimiditide, an aspartimidylated graspetide.

Hader E Elashal, Joseph D Koos, Wai Ling Cheung-Lee, Brian Choi, Li Cao, Michelle A Richardson, Heather L White, A James Link

Open access · greenAbstract read
In one paragraph

Article in Nature chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Repositioning the Leader Peptide in Graspetide Biosynthesis.Journal of the American Chemical Society · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hader E ElashalDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.ORCID 0000-0002-8073-2628
Joseph D KoosDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.ORCID 0000-0001-9613-7949
Wai Ling Cheung-LeeDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.
Brian ChoiDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.ORCID 0000-0003-2976-8577
Li CaoDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.
Michelle A RichardsonDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.ORCID 0000-0002-6029-0949
Heather L WhiteDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.ORCID 0000-0003-2358-2480
A James LinkDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA. ajlink@princeton.edu.ORCID 0000-0001-5066-9691
Princeton University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
Lasso Peptide DiscoveryR01GM107036 · NIGMS · PRINCETON UNIVERSITY · PI LINK, AARON JAMES · 2014 to 2022
$2.9M
NIGMS NIH HHS R01 GM107036NIGMS NIH HHS T32 GM007388
6 · The paper itself

Abstract

Microviridins and other ω-ester-linked peptides, collectively known as graspetides, are characterized by side-chain-side-chain linkages installed by ATP-grasp enzymes. Here we report the discovery of a family of graspetides, the gene clusters of which also encode an O-methyltransferase with homology to the protein repair catalyst protein L-isoaspartyl methyltransferase. Using heterologous expression, we produced fuscimiditide, a ribosomally synthesized and post-translationally modified peptide (RiPP). NMR analysis of fuscimiditide revealed that the peptide contains two ester cross-links forming a stem-loop macrocycle. Furthermore, an unusually stable aspartimide moiety is found within the loop macrocycle. We fully reconstituted fuscimiditide biosynthesis in vitro including formation of the ester and aspartimide moieties. The aspartimide moiety embedded in fuscimiditide hydrolyses regioselectively to isoaspartate. Surprisingly, this isoaspartate-containing peptide is also a substrate for the L-isoaspartyl methyltransferase homologue, thus driving any hydrolysis products back to the aspartimide form. Whereas an aspartimide is often considered a nuisance product in protein formulations, our data suggest that some RiPPs have aspartimide residues intentionally installed via enzymatic activity.

Indexed as

Isoaspartic AcidProtein D-Aspartate-L-Isoaspartate MethyltransferaseAmino Acid SequenceEstersMethyltransferasesPeptidesEstersIsoaspartic AcidMethyltransferasesPeptidesProtein D-Aspartate-L-Isoaspartate Methyltransferase

Identifiers

PMID35982233
PMCPMC10078976
OpenAlexW4292325769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.